Considering molecular alterations as pan-cancer tissue-agnostic targets
Jacob J. Adashek, Shumei Kato, Jason K. Sicklick, Scott M. Lippman, Razelle Kurzrock
Topics & Concepts
Food and drug administrationBiomarkerCancerImmune systemComputational biologyGeneCancer researchBiologyDrugMedicineBioinformaticsPharmacologyImmunologyInternal medicineGeneticsCancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersPARP inhibition in cancer therapy